Healthcare Sector Stocks
The Healthcare sector has a total of 1050 stocks, with a combined market cap of $10.2 trillion, total revenue of $4.71 trillion and a weighted average PE ratio of 48.74.
Market Cap
10.2T
Revenue
4.71T
Profits
209.2B
PE Ratio
48.74
Profit Margin
4.44%
Dividend Yield
0.37%
1050 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.26T | 0.58% | 3,637,366 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 665.26B | 3.82% | 9,820,473 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 520.89B | 3.07% | 8,434,297 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 370.94B | 3.93% | 10,713,502 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 366.84B | 1.23% | 9,524,581 | 450.06B |
| 6 | NVS | Novartis AG | 310.32B | 3.60% | 1,608,334 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 301.05B | 2.78% | 4,555,836 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 261.72B | 1.15% | 2,460,754 | 47.35B |
| 9 | AMGN | Amgen Inc. | 258.61B | 3.70% | 4,621,634 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 216.38B | 4.17% | 9,614,988 | 30.99B |
| 11 | ABT | Abbott Laboratories | 199.94B | 5.62% | 12,711,539 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 198.34B | 4.93% | 26,021,012 | 50.70B |
| 13 | PFE | Pfizer Inc. | 175.44B | 2.60% | 50,587,471 | 63.63B |
| 14 | ISRG | Intuitive Surgical, Inc. | 167.27B | 9.48% | 4,207,711 | 11.58B |
| 15 | DHR | Danaher Corporation | 165.31B | 2.11% | 2,409,079 | 25.61B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 139.27B | 3.49% | 1,833,291 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 131.23B | 4.04% | 14,126,083 | 50.03B |
| 18 | SYK | Stryker Corporation | 129.37B | 9.43% | 6,488,195 | 26.30B |
| 19 | MDT | Medtronic plc | 128.58B | 6.23% | 11,559,673 | 37.54B |
| 20 | MCK | McKesson Corporation | 124.66B | 6.96% | 1,170,707 | 410.98B |
| 21 | SNY | Sanofi | 118.40B | 4.71% | 5,491,919 | 57.89B |
| 22 | GSK | GSK plc | 107.17B | 5.04% | 5,281,261 | 44.53B |
| 23 | HCA | HCA Healthcare, Inc. | 106.69B | 10.34% | 3,446,560 | 78.70B |
| 24 | MRNA | Moderna, Inc. | 103.19B | 13.15% | 14,774,085 | 2.23B |
| 25 | CVS | CVS Health Corporation | 102.32B | -12.48% | 31,962,558 | 418.38B |
| 26 | ELV | Elevance Health, Inc. | 93.80B | 4.94% | 1,729,266 | 201.83B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 93.39B | -4.38% | 1,395,661 | 16.90B |
| 28 | CI | The Cigna Group | 80.71B | 3.38% | 2,430,863 | 282.38B |
| 29 | COR | Cencora, Inc. | 67.57B | 3.99% | 2,346,405 | 337.40B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 66.43B | 1.52% | 2,858,545 | 29.86B |
| 31 | BSX | Boston Scientific Corporation | 66.41B | 5.34% | 34,552,841 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 60.63B | 3.51% | 2,457,078 | 254.25B |
| 33 | ARGX | argenx SE | 59.14B | 3.40% | 646,419 | 5.92B |
| 34 | EW | Edwards Lifesciences Corporation | 57.31B | 4.44% | 6,604,988 | 6.67B |
| 35 | BDX | Becton, Dickinson and Company | 56.94B | 5.49% | 3,894,872 | 22.48B |
| 36 | NTRA | Natera, Inc. | 56.35B | 0.59% | 2,802,764 | 2.71B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 54.97B | 3.82% | 1,395,434 | 4.66B |
| 38 | MDLN | Medline Inc. | 53.09B | 18.45% | 22,900,324 | 30.68B |
| 39 | VEEV | Veeva Systems Inc. | 50.29B | 2.43% | 1,443,053 | 3.46B |
| 40 | HUM | Humana Inc. | 50.10B | -0.15% | 1,596,611 | 145.68B |
| 41 | A | Agilent Technologies, Inc. | 49.95B | 0.97% | 1,641,997 | 7.37B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 48.73B | -0.21% | 8,806,897 | 17.23B |
| 43 | WAT | Waters Corporation | 45.94B | 1.68% | 1,086,270 | 5.61B |
| 44 | IQV | IQVIA Holdings Inc. | 43.47B | 0.46% | 987,145 | 17.31B |
| 45 | ONC | BeOne Medicines AG | 42.83B | 6.10% | 630,632 | 6.13B |
| 46 | RVMD | Revolution Medicines, Inc. | 42.73B | 2.63% | 2,058,094 | - |
| 47 | HLN | Haleon plc | 41.92B | 4.69% | 27,233,364 | 14.80B |
| 48 | ALC | Alcon Inc. | 40.00B | 6.87% | 3,556,753 | 10.86B |
| 49 | RPRX | Royalty Pharma plc | 38.83B | 1.70% | 3,798,910 | 2.62B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 38.82B | 6.43% | 9,614,177 | 21.64B |
| 51 | CNC | Centene Corporation | 37.64B | 12.67% | 13,269,361 | 180.41B |
| 52 | BIIB | Biogen Inc. | 37.62B | 2.23% | 1,348,513 | 10.30B |
| 53 | ZTS | Zoetis Inc. | 36.85B | 7.45% | 9,174,871 | 9.53B |
| 54 | MTD | Mettler-Toledo International Inc. | 34.52B | 1.46% | 174,055 | 4.13B |
| 55 | ILMN | Illumina, Inc. | 34.27B | -4.84% | 3,025,806 | 4.54B |
| 56 | RMD | ResMed Inc. | 33.82B | 5.90% | 2,258,238 | 5.73B |
| 57 | DXCM | DexCom, Inc. | 32.99B | 6.62% | 5,251,703 | 5.10B |
| 58 | GMAB | Genmab A/S | 31.86B | -0.76% | 4,293,020 | 4.13B |
| 59 | PHG | Koninklijke Philips N.V. | 30.02B | 9.07% | 3,023,836 | 20.16B |
| 60 | LH | Labcorp Holdings Inc. | 29.86B | 3.91% | 633,885 | 14.59B |
| 61 | WST | West Pharmaceutical Services, Inc. | 28.47B | 0.42% | 1,054,869 | 3.40B |
| 62 | DGX | Quest Diagnostics Incorporated | 28.12B | 3.46% | 748,156 | 11.84B |
| 63 | ROIV | Roivant Sciences Ltd. | 27.61B | 6.05% | 11,671,485 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 26.05B | 1.01% | 946,783 | 3.19B |
| 65 | INCY | Incyte Corporation | 25.05B | 4.52% | 2,061,813 | 6.01B |
| 66 | STE | STERIS plc | 24.17B | 7.16% | 1,379,977 | 6.17B |
| 67 | INSM | Insmed Incorporated | 24.12B | 5.28% | 4,939,890 | 1.52B |
| 68 | THC | Tenet Healthcare Corporation | 23.19B | 9.24% | 2,085,691 | 22.15B |
| 69 | GH | Guardant Health, Inc. | 22.66B | -3.51% | 2,236,143 | 1.18B |
| 70 | BNTX | BioNTech SE | 22.46B | 4.21% | 1,353,529 | 2.75B |
| 71 | VTRS | Viatris Inc. | 22.12B | 1.77% | 8,450,999 | 14.74B |
| 72 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.55B | 0.64% | 3,639,052 | 5.01B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 20.99B | 13.38% | 6,169,907 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.38B | -0.97% | 233,120 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 17.79B | -2.48% | 2,363,884 | 2.94B |
| 76 | EXEL | Exelixis, Inc. | 17.76B | 0.65% | 3,015,774 | 2.50B |
| 77 | ASND | Ascendis Pharma A/S | 16.95B | 3.15% | 655,900 | 1.20B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 16.88B | 0.72% | 2,222,122 | 3.70B |
| 79 | CRL | Charles River Laboratories International, Inc. | 15.58B | -7.26% | 1,524,334 | 3.98B |
| 80 | ICLR | ICON Public Limited Company | 15.22B | -0.33% | 1,263,378 | 8.23B |
| 81 | SOLV | Solventum Corporation | 15.19B | 5.29% | 1,496,712 | 8.31B |
| 82 | BBIO | BridgeBio Pharma, Inc. | 15.18B | 5.28% | 5,558,598 | 945.54M |
| 83 | JAZZ | Jazz Pharmaceuticals plc | 15.06B | 2.11% | 898,454 | 4.72B |
| 84 | HALO | Halozyme Therapeutics, Inc. | 14.79B | 1.34% | 1,612,150 | 1.66B |
| 85 | GKOS | Glaukos Corporation | 14.65B | 6.25% | 2,081,048 | 690.33M |
| 86 | BTSG | BrightSpring Health Services, Inc. | 14.53B | -0.11% | 3,089,607 | 15.25B |
| 87 | SNN | Smith & Nephew plc | 14.43B | 7.61% | 2,611,265 | 6.30B |
| 88 | EHC | Encompass Health Corporation | 13.84B | 4.62% | 826,982 | 6.34B |
| 89 | TEM | Tempus AI, Inc. | 13.79B | -2.80% | 5,934,622 | 1.51B |
| 90 | BAX | Baxter International Inc. | 13.70B | 3.86% | 8,822,500 | 11.61B |
| 91 | SMMT | Summit Therapeutics Inc. | 12.94B | 2.41% | 4,258,115 | - |
| 92 | FMS | Fresenius Medical Care AG | 12.71B | 6.67% | 2,310,297 | 22.12B |
| 93 | PEN | Penumbra, Inc. | 12.71B | 0.77% | 327,189 | 1.56B |
| 94 | ELAN | Elanco Animal Health Incorporated | 12.64B | 2.97% | 6,156,373 | 5.02B |
| 95 | COO | The Cooper Companies, Inc. | 12.24B | 5.80% | 3,269,297 | 4.24B |
| 96 | DVA | DaVita Inc. | 12.11B | 5.69% | 1,158,950 | 14.17B |
| 97 | RDY | Dr. Reddy's Laboratories Limited | 12.09B | 3.25% | 2,114,904 | 3.44B |
| 98 | MOH | Molina Healthcare, Inc. | 11.78B | 8.84% | 1,788,349 | 42.08B |
| 99 | ALGN | Align Technology, Inc. | 11.74B | 9.02% | 1,698,387 | 4.16B |
| 100 | GMED | Globus Medical, Inc. | 11.69B | 9.41% | 2,035,056 | 3.14B |
| 101 | KYMR | Kymera Therapeutics, Inc. | 11.64B | 7.29% | 1,403,595 | 102.24M |
| 102 | UHS | Universal Health Services, Inc. | 11.58B | 10.94% | 1,427,837 | 18.35B |
| 103 | PODD | Insulet Corporation | 11.44B | 6.55% | 2,605,206 | 3.05B |
| 104 | TECH | Bio-Techne Corporation | 11.41B | 0.11% | 4,212,150 | 1.22B |
| 105 | RGEN | Repligen Corporation | 11.40B | 0.01% | 1,058,319 | 805.61M |
| 106 | BMRN | BioMarin Pharmaceutical Inc. | 11.06B | 2.68% | 3,224,571 | 3.66B |
| 107 | ENSG | The Ensign Group, Inc. | 10.91B | 3.55% | 527,469 | 5.67B |
| 108 | OSCR | Oscar Health, Inc. | 10.84B | 8.52% | 12,432,678 | 15.32B |
| 109 | AVTR | Avantor, Inc. | 10.60B | 0.38% | 8,172,345 | 6.64B |
| 110 | QGEN | Qiagen N.V. | 10.51B | 0.85% | 2,951,683 | 2.10B |
| 111 | PCVX | Vaxcyte, Inc. | 10.33B | 7.96% | 2,258,522 | - |
| 112 | BIO | Bio-Rad Laboratories, Inc. | 10.15B | 1.23% | 232,943 | 2.59B |
| 113 | HSIC | Henry Schein, Inc. | 9.83B | 6.95% | 3,898,906 | 13.73B |
| 114 | HNGE | Hinge Health, Inc. | 9.76B | 3.48% | 2,063,590 | 800.82M |
| 115 | BRKR | Bruker Corporation | 9.73B | 13.03% | 7,413,113 | 3.51B |
| 116 | IBRX | ImmunityBio, Inc. | 9.47B | 7.78% | 9,738,515 | 165.79M |
| 117 | CAI | Caris Life Sciences, Inc. | 9.38B | 1.10% | 4,095,283 | 989.61M |
| 118 | ATR | AptarGroup, Inc. | 9.32B | 3.31% | 504,897 | 3.99B |
| 119 | PTGX | Protagonist Therapeutics, Inc. | 9.28B | 2.23% | 777,777 | 281.99M |
| 120 | SYRE | Spyre Therapeutics, Inc. | 9.27B | -0.08% | 1,496,148 | - |
| 121 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.26B | 1.12% | 2,314,770 | 1.43B |
| 122 | KRYS | Krystal Biotech, Inc. | 9.20B | 1.77% | 414,313 | 470.03M |
| 123 | HQY | HealthEquity, Inc. | 8.99B | 6.57% | 1,570,741 | 1.36B |
| 124 | TWST | Twist Bioscience Corporation | 8.95B | 1.71% | 2,008,312 | 431.80M |
| 125 | CYTK | Cytokinetics, Incorporated | 8.93B | 3.05% | 2,921,326 | 67.67M |
| 126 | TXG | 10x Genomics, Inc. | 8.79B | 3.34% | 2,925,127 | 616.91M |
| 127 | TGTX | TG Therapeutics, Inc. | 8.74B | 1.50% | 2,041,233 | 799.54M |
| 128 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.71B | 3.61% | 1,616,454 | 669.50M |
| 129 | CORT | Corcept Therapeutics Incorporated | 8.56B | -3.33% | 2,197,200 | 963.65M |
| 130 | PACS | PACS Group, Inc. | 7.98B | 7.70% | 1,609,944 | 5.71B |
| 131 | PRAX | Praxis Precision Medicines, Inc. | 7.94B | 1.32% | 372,859 | 7.46M |
| 132 | ABVX | ABIVAX Société Anonyme | 7.78B | 0.79% | 568,155 | 5.33M |
| 133 | ALKS | Alkermes plc | 7.70B | 0.45% | 2,180,663 | 1.75B |
| 134 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.55B | 3.03% | 861,314 | 945.96M |
| 135 | GRFS | Grifols, S.A. | 7.54B | 0.47% | 675,067 | 8.63B |
| 136 | BLCO | Bausch + Lomb Corporation | 7.38B | 3.02% | 1,129,422 | 5.42B |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.24B | 21.67% | 3,684,624 | 280.75M |
| 138 | AXSM | Axsome Therapeutics, Inc. | 7.20B | -1.97% | 1,034,337 | 865.27M |
| 139 | CHE | Chemed Corporation | 7.12B | 2.95% | 227,189 | 2.66B |
| 140 | AMRX | Amneal Pharmaceuticals, Inc. | 6.95B | -1.31% | 7,236,498 | 3.20B |
| 141 | ORKA | Oruka Therapeutics, Inc. | 6.71B | 1.88% | 790,947 | - |
| 142 | IONS | Ionis Pharmaceuticals, Inc. | 6.67B | -0.67% | 4,101,895 | 874.09M |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.60B | 0.31% | 1,096,202 | 1.56B |
| 144 | GRAL | GRAIL, Inc. | 6.39B | 2.59% | 756,573 | 165.26M |
| 145 | TFX | Teleflex Incorporated | 6.35B | 7.16% | 1,127,345 | 2.25B |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 6.32B | 0.82% | 179,953 | 253.83M |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 6.31B | 11.61% | 1,154,484 | 670.78M |
| 148 | RDNT | RadNet, Inc. | 6.30B | 9.40% | 1,727,825 | 2.27B |
| 149 | HIMS | Hims & Hers Health, Inc. | 6.22B | 3.72% | 10,750,078 | 2.58B |
| 150 | DOCS | Doximity, Inc. | 6.18B | 6.35% | 2,999,975 | 655.57M |
| 151 | IMVT | Immunovant, Inc. | 6.17B | 2.89% | 1,271,465 | - |
| 152 | KOD | Kodiak Sciences Inc. | 6.15B | -0.79% | 1,003,499 | - |
| 153 | BLTE | Belite Bio, Inc | 6.14B | 0.22% | 82,863 | - |
| 154 | CGON | CG Oncology, Inc. | 6.00B | 5.67% | 1,305,118 | 6.23M |
| 155 | HAE | Haemonetics Corporation | 5.79B | 5.84% | 981,975 | 1.35B |
| 156 | PTCT | PTC Therapeutics, Inc. | 5.75B | 1.07% | 1,344,523 | 1.16B |
| 157 | MANE | Veradermics, Incorporated | 5.70B | 2.14% | 515,339 | - |
| 158 | WAY | Waystar Holding Corp. | 5.69B | 7.34% | 3,263,884 | 1.26B |
| 159 | SRRK | Scholar Rock Holding Corporation | 5.61B | 4.76% | 1,712,386 | - |
| 160 | CON | Concentra Group Holdings Parent, Inc. | 5.55B | 8.44% | 2,238,591 | 2.29B |
| 161 | COGT | Cogent Biosciences, Inc. | 5.46B | 1.34% | 1,837,993 | - |
| 162 | MMSI | Merit Medical Systems, Inc. | 5.43B | 7.71% | 1,388,828 | 1.61B |
| 163 | LFST | LifeStance Health Group, Inc. | 5.43B | 6.25% | 4,043,346 | 1.58B |
| 164 | MMED | MiniMed Group, Inc. | 5.43B | 2.33% | 11,794,367 | 3.22B |
| 165 | BLLN | BillionToOne, Inc. | 5.36B | 2.75% | 582,731 | 397.41M |
| 166 | ERAS | Erasca, Inc. | 5.22B | 1.91% | 3,504,228 | - |
| 167 | LIVN | LivaNova PLC | 5.19B | 17.96% | 3,785,442 | 1.51B |
| 168 | TVTX | Travere Therapeutics, Inc. | 5.03B | 6.09% | 3,670,491 | 651.03M |
| 169 | CRSP | CRISPR Therapeutics AG | 5.02B | 3.54% | 1,394,323 | 25.17M |
| 170 | HTFL | HeartFlow, Inc. | 4.91B | 3.90% | 1,587,481 | 212.07M |
| 171 | DNTH | Dianthus Therapeutics, Inc. | 4.80B | 3.75% | 1,679,746 | 1.90M |
| 172 | OPCH | Option Care Health, Inc. | 4.74B | -0.31% | 4,318,607 | 5.75B |
| 173 | SHC | Sotera Health Company | 4.68B | 2.18% | 4,620,252 | 1.23B |
| 174 | CDNA | CareDx, Inc. | 4.51B | -3.01% | 1,459,469 | 497.40M |
| 175 | IRTC | iRhythm Holdings, Inc. | 4.42B | 6.07% | 1,191,706 | 825.34M |
| 176 | LEGN | Legend Biotech Corporation | 4.41B | 5.98% | 3,156,157 | 1.27B |
| 177 | DFTX | Definium Therapeutics, Inc. | 4.39B | -2.13% | 1,415,230 | - |
| 178 | NVST | Envista Holdings Corporation | 4.38B | 9.97% | 5,459,563 | 2.88B |
| 179 | ICUI | ICU Medical, Inc. | 4.32B | 6.71% | 446,897 | 2.16B |
| 180 | ARQT | Arcutis Biotherapeutics, Inc. | 4.31B | 7.09% | 2,066,696 | 508.68M |
| 181 | ITGR | Integer Holdings Corporation | 4.31B | 0.08% | 548,161 | 1.83B |
| 182 | ADPT | Adaptive Biotechnologies Corporation | 4.26B | 3.37% | 2,330,171 | 308.08M |
| 183 | LQDA | Liquidia Corporation | 4.24B | 12.31% | 4,819,411 | 450.91M |
| 184 | VCYT | Veracyte, Inc. | 4.23B | 4.63% | 1,443,832 | 561.90M |
| 185 | EWTX | Edgewise Therapeutics, Inc. | 4.07B | -0.49% | 1,081,889 | - |
| 186 | PLSE | Pulse Biosciences, Inc. | 4.07B | 9.37% | 499,704 | 1.19M |
| 187 | ABCL | AbCellera Biologics Inc. | 3.98B | 0.82% | 2,337,802 | 66.17M |
| 188 | IOVA | Iovance Biotherapeutics, Inc. | 3.96B | -1.02% | 17,961,762 | 324.97M |
| 189 | RLAY | Relay Therapeutics, Inc. | 3.95B | 3.35% | 3,732,285 | 10.35M |
| 190 | TNGX | Tango Therapeutics, Inc. | 3.91B | 0.04% | 2,465,972 | 53.81M |
| 191 | XENE | Xenon Pharmaceuticals Inc. | 3.80B | 2.51% | 1,632,807 | 7.50M |
| 192 | PBLS | Parabilis Medicines, Inc. | 3.76B | 3.93% | 843,320 | 148.00K |
| 193 | ACAD | Acadia Pharmaceuticals Inc. | 3.70B | 4.50% | 4,723,519 | 1.14B |
| 194 | IRON | Disc Medicine, Inc. | 3.69B | 2.51% | 1,428,353 | - |
| 195 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.67B | 0.24% | 1,587,117 | -665.00K |
| 196 | STVN | Stevanato Group S.p.A. | 3.64B | -5.35% | 4,231,873 | 1.42B |
| 197 | OGN | Organon & Co. | 3.64B | 0.04% | 1,611,139 | 6.10B |
| 198 | VKTX | Viking Therapeutics, Inc. | 3.57B | 7.21% | 4,383,285 | - |
| 199 | ELVN | Enliven Therapeutics, Inc. | 3.46B | 5.47% | 2,709,366 | - |
| 200 | DYN | Dyne Therapeutics, Inc. | 3.46B | 2.74% | 3,652,240 | - |
| 201 | TARS | Tarsus Pharmaceuticals, Inc. | 3.40B | -5.01% | 2,552,422 | 682.20M |
| 202 | TLX | Telix Pharmaceuticals Limited | 3.39B | 7.09% | 532,374 | 890.79M |
| 203 | CELC | Celcuity Inc. | 3.38B | -0.79% | 1,201,631 | - |
| 204 | DNLI | Denali Therapeutics Inc. | 3.35B | 7.76% | 4,905,798 | 21.38M |
| 205 | ATRC | AtriCure, Inc. | 3.33B | 8.53% | 1,336,734 | 589.80M |
| 206 | SUPN | Supernus Pharmaceuticals, Inc. | 3.33B | 0.28% | 6,570,306 | 1.37B |
| 207 | NHC | National HealthCare Corporation | 3.32B | 3.07% | 207,011 | 1.56B |
| 208 | VRDN | Viridian Therapeutics, Inc. | 3.29B | 15.45% | 11,184,584 | 26.31M |
| 209 | IDYA | IDEAYA Biosciences, Inc. | 3.13B | 3.19% | 2,034,306 | 36.54M |
| 210 | BHC | Bausch Health Companies Inc. | 3.12B | 2.52% | 3,317,224 | 11.11B |
| 211 | AVAH | Aveanna Healthcare Holdings Inc. | 3.11B | 7.34% | 3,799,362 | 2.60B |
| 212 | AXGN | Axogen, Inc. | 3.06B | 3.64% | 1,867,230 | 266.93M |
| 213 | SGRY | Surgery Partners, Inc. | 3.00B | 0.13% | 11,096,700 | 3.37B |
| 214 | ACHC | Acadia Healthcare Company, Inc. | 3.00B | 8.88% | 5,061,028 | 3.41B |
| 215 | PRVA | Privia Health Group, Inc. | 2.86B | 4.15% | 2,820,101 | 2.36B |
| 216 | ZLAB | Zai Lab Limited | 2.83B | 3.98% | 1,169,717 | 449.61M |
| 217 | RCUS | Arcus Biosciences, Inc. | 2.78B | 2.38% | 2,078,147 | 117.00M |
| 218 | BEAM | Beam Therapeutics Inc. | 2.77B | 5.45% | 1,348,975 | 146.64M |
| 219 | NEOG | Neogen Corporation | 2.72B | 2.98% | 4,515,907 | 884.00M |
| 220 | RGC | Regencell Bioscience Holdings Limited | 2.68B | -12.20% | 274,081 | - |
| 221 | BKD | Brookdale Senior Living Inc. | 2.67B | 8.00% | 5,173,732 | 2.93B |
| 222 | GRDN | Guardian Pharmacy Services, Inc. | 2.67B | 2.91% | 589,311 | 1.46B |
| 223 | WRBY | Warby Parker Inc. | 2.63B | -3.05% | 8,618,828 | 911.61M |
| 224 | XNCR | Xencor, Inc. | 2.60B | 14.23% | 2,538,472 | 104.97M |
| 225 | HCM | HUTCHMED (China) Limited | 2.56B | 6.12% | 101,547 | 549.12M |
| 226 | UFPT | UFP Technologies, Inc. | 2.55B | 17.54% | 358,516 | 649.52M |
| 227 | MBX | MBX Biosciences, Inc. | 2.53B | -4.55% | 425,481 | - |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.53B | 7.59% | 652,609 | 1.10B |
| 229 | TMDX | TransMedics Group, Inc. | 2.52B | 7.89% | 2,473,721 | 668.47M |
| 230 | MD | Pediatrix Medical Group, Inc. | 2.51B | 7.55% | 883,423 | 1.96B |
| 231 | NAMS | NewAmsterdam Pharma Company N.V. | 2.50B | 5.00% | 1,890,931 | 25.94M |
| 232 | CLOV | Clover Health Investments, Corp. | 2.48B | 8.86% | 7,279,310 | 2.48B |
| 233 | PHVS | Pharvaris N.V. | 2.41B | -1.15% | 262,155 | - |
| 234 | RXRX | Recursion Pharmaceuticals, Inc. | 2.41B | 5.03% | 19,430,876 | 68.23M |
| 235 | CLDX | Celldex Therapeutics, Inc. | 2.35B | 0.69% | 912,328 | 158.00K |
| 236 | ADMA | ADMA Biologics, Inc. | 2.35B | -5.76% | 11,145,844 | 512.28M |
| 237 | ADUS | Addus HomeCare Corporation | 2.34B | 1.26% | 422,086 | 1.50B |
| 238 | VCEL | Vericel Corporation | 2.33B | 10.64% | 1,808,435 | 306.30M |
| 239 | PVLA | Palvella Therapeutics, Inc. | 2.32B | 5.39% | 407,368 | - |
| 240 | IMNM | Immunome, Inc. | 2.31B | -3.57% | 3,452,354 | 4.02M |
| 241 | PGNY | Progyny, Inc. | 2.31B | 3.54% | 1,244,885 | 1.34B |
| 242 | VERA | Vera Therapeutics, Inc. | 2.31B | 4.17% | 1,986,542 | - |
| 243 | BHVN | Biohaven Ltd. | 2.30B | -2.37% | 1,675,767 | - |
| 244 | AUPH | Aurinia Pharmaceuticals Inc. | 2.29B | 3.35% | 1,477,573 | 321.74M |
| 245 | SEPN | Septerna, Inc. | 2.23B | 9.52% | 605,146 | 98.88M |
| 246 | TRLV | Trulieve Cannabis Corp. | 2.23B | 0.35% | 2,248,297 | 1.14B |
| 247 | NEO | NeoGenomics, Inc. | 2.22B | 1.84% | 1,150,735 | 787.75M |
| 248 | PRGO | Perrigo Company plc | 2.20B | 0.89% | 4,972,071 | 4.09B |
| 249 | ZYME | Zymeworks Inc. | 2.20B | 2.67% | 1,047,380 | 37.13M |
| 250 | LKFT | Lakefront Biotherapeutics NV | 2.14B | 6.10% | 447,400 | 1.13B |
| 251 | SDGR | Schrödinger, Inc. | 2.14B | 5.19% | 1,898,862 | 259.04M |
| 252 | XRAY | DENTSPLY SIRONA Inc. | 2.12B | 9.35% | 6,689,251 | 3.64B |
| 253 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.11B | -3.62% | 10,228,483 | 961.51M |
| 254 | COAG | Hemab Therapeutics Holdings, Inc. | 2.10B | 4.52% | 499,858 | - |
| 255 | WGS | GeneDx Holdings Corp. | 2.07B | 1.33% | 550,990 | 454.43M |
| 256 | TRAX | First Tracks Biotherapeutics, Inc. | 2.06B | 5.61% | 940,612 | - |
| 257 | ASTH | Astrana Health, Inc. | 2.03B | 7.98% | 461,691 | 3.84B |
| 258 | LMAT | LeMaitre Vascular, Inc. | 2.01B | 9.18% | 521,281 | 262.43M |
| 259 | HRMY | Harmony Biosciences Holdings, Inc. | 2.01B | -6.82% | 2,448,953 | 989.36M |
| 260 | FTRE | Fortrea Holdings Inc. | 2.01B | -0.64% | 1,433,262 | 2.67B |
| 261 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.01B | 3.83% | 3,626,877 | 213.00M |
| 262 | SRPT | Sarepta Therapeutics, Inc. | 2.01B | 2.48% | 1,483,996 | 1.97B |
| 263 | ESTA | Establishment Labs Holdings Inc. | 2.00B | 9.36% | 383,810 | 264.03M |
| 264 | TRVI | Trevi Therapeutics, Inc. | 1.99B | 1.01% | 1,379,056 | - |
| 265 | VIR | Vir Biotechnology, Inc. | 1.99B | 4.95% | 2,806,517 | 303.23M |
| 266 | REPL | Replimune Group, Inc. | 1.96B | 0.12% | 3,216,679 | - |
| 267 | INSP | Inspire Medical Systems, Inc. | 1.93B | 7.50% | 750,737 | 880.94M |
| 268 | MESO | Mesoblast Limited | 1.91B | -3.22% | 357,322 | 120.25M |
| 269 | XERS | Xeris Biopharma Holdings, Inc. | 1.91B | 1.21% | 3,159,781 | 335.41M |
| 270 | ALMR | Alamar Biosciences, Inc. | 1.89B | -10.06% | 1,530,333 | 114.05M |
| 271 | AGIO | Agios Pharmaceuticals, Inc. | 1.88B | 0.67% | 1,107,822 | 98.34M |
| 272 | ZBIO | Zenas BioPharma, Inc. | 1.85B | 0.11% | 802,136 | 1.00M |
| 273 | AMN | AMN Healthcare Services, Inc. | 1.85B | 5.47% | 422,836 | 3.43B |
| 274 | SLS | SELLAS Life Sciences Group, Inc. | 1.85B | 3.16% | 4,882,467 | - |
| 275 | ARDT | Ardent Health, Inc. | 1.83B | 10.93% | 1,076,528 | 6.41B |
| 276 | GENB | Generate Biomedicines, Inc. | 1.82B | 2.31% | 635,510 | 26.48M |
| 277 | PGEN | Precigen, Inc. | 1.81B | -3.52% | 10,450,476 | 85.72M |
| 278 | BFLY | Butterfly Network, Inc. | 1.81B | 5.78% | 5,197,078 | 123.26M |
| 279 | KMTS | Kestra Medical Technologies, Ltd. | 1.81B | 4.69% | 1,894,296 | 106.73M |
| 280 | ABSI | Absci Corporation | 1.80B | 5.00% | 4,161,377 | 1.56M |
| 281 | HCSG | Healthcare Services Group, Inc. | 1.80B | 4.34% | 693,148 | 1.88B |
| 282 | OMCL | Omnicell, Inc. | 1.80B | 11.13% | 851,067 | 1.24B |
| 283 | MAZE | Maze Therapeutics, Inc. | 1.79B | 3.16% | 536,608 | 20.00M |
| 284 | STOK | Stoke Therapeutics, Inc. | 1.79B | 1.57% | 1,210,964 | 28.21M |
| 285 | TDOC | Teladoc Health, Inc. | 1.77B | 9.06% | 7,281,328 | 2.47B |
| 286 | NVAX | Novavax, Inc. | 1.76B | 10.07% | 6,024,992 | 413.80M |
| 287 | SNDA | Sonida Senior Living, Inc. | 1.75B | 8.68% | 562,668 | 481.07M |
| 288 | NRIX | Nurix Therapeutics, Inc. | 1.74B | -38.23% | 19,576,385 | 701.94M |
| 289 | NTLA | Intellia Therapeutics, Inc. | 1.72B | 3.79% | 3,173,028 | 59.51M |
| 290 | AZTA | Azenta, Inc. | 1.72B | 5.41% | 916,915 | 613.81M |
| 291 | NVCR | NovoCure Limited | 1.71B | 8.75% | 1,650,008 | 725.39M |
| 292 | ALHC | Alignment Healthcare, Inc. | 1.70B | 10.08% | 4,387,098 | 4.94B |
| 293 | CERT | Certara, Inc. | 1.69B | 2.12% | 2,427,051 | 421.75M |
| 294 | PSNL | Personalis, Inc. | 1.69B | 0.29% | 2,218,774 | 69.67M |
| 295 | RARE | Ultragenyx Pharmaceutical Inc. | 1.69B | 3.19% | 7,515,414 | 730.00M |
| 296 | ADRX | ADARx Pharmaceuticals, Inc. | 1.68B | -7.02% | 378,011 | 6.13M |
| 297 | ALVO | Alvotech | 1.67B | 3.08% | 669,302 | 494.61M |
| 298 | KLRA | Kailera Therapeutics, Inc. | 1.66B | 1.67% | 651,030 | - |
| 299 | NUVB | Nuvation Bio Inc. | 1.66B | 0.64% | 7,349,113 | 169.90M |
| 300 | LYCA | Lycia Therapeutics, Inc. | 1.64B | 3.19% | 302,719 | 4.44M |
| 301 | BRVE | Braveheart Bio, Inc. | 1.64B | -6.08% | 655,995 | - |
| 302 | AGL | agilon health, inc. | 1.61B | 9.19% | 282,850 | 6.00B |
| 303 | PAHC | Phibro Animal Health Corporation | 1.60B | 4.62% | 266,865 | 1.52B |
| 304 | QURE | uniQure N.V. | 1.60B | -3.44% | 2,663,059 | 20.17M |
| 305 | CNMD | CONMED Corporation | 1.59B | 13.25% | 470,715 | 1.37B |
| 306 | OCUL | Ocular Therapeutix, Inc. | 1.57B | 4.84% | 3,361,597 | 52.06M |
| 307 | PNTG | The Pennant Group, Inc. | 1.54B | 6.87% | 365,526 | 1.10B |
| 308 | INVA | Innoviva, Inc. | 1.54B | 1.58% | 919,736 | 440.00M |
| 309 | ANIP | ANI Pharmaceuticals, Inc. | 1.54B | -0.84% | 304,941 | 978.38M |
| 310 | NBTX | Nanobiotix S.A. | 1.53B | 4.10% | 230,335 | 13.15M |
| 311 | RAPP | Rapport Therapeutics, Inc. | 1.53B | 1.77% | 957,528 | 20.00M |
| 312 | IMCR | Immunocore Holdings plc | 1.50B | -2.70% | 684,218 | 430.78M |
| 313 | MLYS | Mineralys Therapeutics, Inc. | 1.50B | 6.19% | 1,925,641 | - |
| 314 | TYRA | Tyra Biosciences, Inc. | 1.48B | 0.70% | 542,857 | - |
| 315 | KARD | Kardigan, Inc. | 1.46B | 8.73% | 490,805 | - |
| 316 | GPCR | Structure Therapeutics Inc. | 1.46B | 0.29% | 736,576 | - |
| 317 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.08% | 2,422,580 | 746.16M |
| 318 | ETON | Eton Pharmaceuticals, Inc. | 1.45B | -0.55% | 375,863 | 105.60M |
| 319 | TSHA | Taysha Gene Therapies, Inc. | 1.42B | 6.85% | 4,037,075 | 5.49M |
| 320 | DMRA | Damora Therapeutics, Inc. | 1.42B | 3.89% | 736,970 | - |
| 321 | ANAB | AnaptysBio, Inc. | 1.41B | -1.01% | 528,365 | 106.09M |
| 322 | NUTX | Nutex Health Inc. | 1.41B | 14.50% | 164,599 | 846.72M |
| 323 | ENOV | Enovis Corporation | 1.41B | 16.80% | 3,386,981 | 2.30B |
| 324 | URGN | UroGen Pharma Ltd. | 1.40B | -16.53% | 2,890,769 | 250.25M |
| 325 | KRSA | Korsana Biosciences, Inc. | 1.38B | -5.01% | 122,724 | - |
| 326 | STAA | STAAR Surgical Company | 1.37B | 8.16% | 980,923 | 339.59M |
| 327 | GHRS | GH Research PLC | 1.36B | -2.07% | 298,881 | - |
| 328 | INNV | InnovAge Holding Corp. | 1.34B | 10.68% | 1,079,507 | 1.02B |
| 329 | OPK | OPKO Health, Inc. | 1.34B | 4.07% | 4,833,524 | 587.90M |
| 330 | USPH | U.S. Physical Therapy, Inc. | 1.33B | 5.69% | 216,848 | 804.27M |
| 331 | TNDM | Tandem Diabetes Care, Inc. | 1.32B | 7.82% | 3,717,878 | 1.04B |
| 332 | OMER | Omeros Corporation | 1.32B | -0.55% | 976,427 | 38.42M |
| 333 | LBRX | LB Pharmaceuticals Inc | 1.32B | 1.09% | 365,774 | - |
| 334 | NKTR | Nektar Therapeutics | 1.30B | 1.17% | 498,476 | 54.59M |
| 335 | CRON | Cronos Group Inc. | 1.30B | 3.99% | 2,116,047 | 179.09M |
| 336 | DRTS | Alpha Tau Medical Ltd. | 1.30B | 3.62% | 687,266 | - |
| 337 | AORT | Artivion, Inc. | 1.29B | 11.35% | 927,654 | 471.47M |
| 338 | ATEC | Alphatec Holdings, Inc. | 1.28B | 10.84% | 6,268,272 | 839.72M |
| 339 | AAPG | Ascentage Pharma Group International | 1.28B | 7.72% | 19,657 | 94.61M |
| 340 | GDRX | GoodRx Holdings, Inc. | 1.27B | 6.59% | 2,107,932 | 785.23M |
| 341 | MNKD | MannKind Corporation | 1.27B | 5.63% | 4,056,537 | 393.63M |
| 342 | LMRI | Lumexa Imaging Holdings, Inc. | 1.26B | 16.80% | 1,333,757 | 1.04B |
| 343 | INBX | Inhibrx Biosciences, Inc. | 1.26B | 5.32% | 190,201 | 1.30M |
| 344 | PRCT | PROCEPT BioRobotics Corporation | 1.24B | 7.49% | 2,491,144 | 337.34M |
| 345 | VOR | Vor Biopharma Inc. | 1.23B | 0.81% | 416,201 | - |
| 346 | FRNM | Freenome, Inc. | 1.21B | -1.83% | 757,311 | 35.41M |
| 347 | AVLN | Avalyn Pharma Inc. | 1.20B | 1.12% | 457,020 | - |
| 348 | VSTM | Verastem, Inc. | 1.20B | 0.97% | 2,263,927 | 87.53M |
| 349 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.19B | 3.39% | 306,937 | 730.02M |
| 350 | SLN | Silence Therapeutics plc | 1.19B | 0.08% | 1,024,324 | 615.00K |
| 351 | CMPS | COMPASS Pathways plc | 1.19B | - | 5,258,280 | - |
| 352 | OMDA | Omada Health, Inc. | 1.19B | 4.44% | 707,666 | 309.76M |
| 353 | SVRA | Savara Inc. | 1.18B | -1.89% | 3,564,490 | - |
| 354 | SGP | SpyGlass Pharma, Inc. | 1.17B | 1.39% | 201,112 | - |
| 355 | IART | Integra LifeSciences Holdings Corporation | 1.15B | 8.80% | 1,172,512 | 1.66B |
| 356 | AHG | Akso Health Group | 1.14B | 9.92% | 8,994 | 13.83M |
| 357 | IRMD | IRADIMED CORPORATION | 1.13B | 9.15% | 184,542 | 89.34M |
| 358 | SPTX | Seaport Therapeutics, Inc. | 1.13B | 4.21% | 336,428 | - |
| 359 | SIBN | SI-BONE, Inc. | 1.13B | 4.92% | 2,188,361 | 220.65M |
| 360 | JANX | Janux Therapeutics, Inc. | 1.11B | 1.96% | 974,481 | 24.00M |
| 361 | CSTL | Castle Biosciences, Inc. | 1.09B | 1.82% | 462,720 | 357.28M |
| 362 | HROW | Harrow, Inc. | 1.08B | 0.77% | 776,023 | 275.59M |
| 363 | CBLL | CeriBell, Inc. | 1.05B | -3.18% | 1,272,344 | 108.72M |
| 364 | HSTM | HealthStream, Inc. | 997.43M | 2.94% | 310,640 | 327.95M |
| 365 | MLTX | MoonLake Immunotherapeutics | 984.26M | -1.15% | 1,228,151 | - |
| 366 | QDEL | QuidelOrtho Corporation | 982.69M | 1.70% | 3,286,596 | 2.59B |
| 367 | AHCO | AdaptHealth Corp. | 973.87M | 16.08% | 6,336,734 | 3.44B |
| 368 | ORIC | ORIC Pharmaceuticals, Inc. | 969.15M | -2.50% | 2,960,056 | - |
| 369 | GMRS | GMR Solutions Inc. | 962.97M | 8.78% | 1,047,142 | 5.88B |
| 370 | BVS | Bioventus Inc. | 961.17M | 4.43% | 1,265,728 | 585.64M |
| 371 | RIGL | Rigel Pharmaceuticals, Inc. | 957.53M | 4.91% | 288,783 | 276.79M |
| 372 | JBIO | Jade Biosciences, Inc. | 956.50M | 3.23% | 1,136,988 | - |
| 373 | LTGO | Latigo Biotherapeutics, Inc. | 951.40M | -1.51% | 156,053 | - |
| 374 | IMTX | Immatics N.V. | 943.16M | -2.47% | 678,886 | 47.65M |
| 375 | SNDX | Syndax Pharmaceuticals, Inc. | 934.94M | -26.73% | 15,066,613 | 289.68M |
| 376 | ODTX | Odyssey Therapeutics, Inc. | 927.22M | -10.29% | 675,899 | 99.00K |
| 377 | GLUE | Monte Rosa Therapeutics, Inc. | 921.81M | 3.79% | 1,427,709 | 28.73M |
| 378 | BBNX | Beta Bionics, Inc. | 920.71M | 12.15% | 1,179,391 | 127.27M |
| 379 | ANRO | Alto Neuroscience, Inc. | 911.99M | 2.38% | 377,054 | - |
| 380 | MGTX | MeiraGTx Holdings plc | 904.73M | -1.05% | 597,873 | 397.50M |
| 381 | IVA | Inventiva S.A. | 903.82M | -3.85% | 1,577,152 | 2.81M |
| 382 | CRVS | Corvus Pharmaceuticals, Inc. | 890.00M | 7.63% | 1,960,121 | - |
| 383 | PRME | Prime Medicine, Inc. | 882.41M | 9.01% | 4,401,540 | 4.07M |
| 384 | KIDS | OrthoPediatrics Corp. | 876.66M | 6.89% | 555,291 | 264.14M |
| 385 | ALMS | Alumis Inc. | 849.10M | 0.92% | 1,291,646 | 7.40M |
| 386 | AKTS | Aktis Oncology, Inc. | 844.58M | 1.64% | 243,405 | 10.06M |
| 387 | PHAR | Pharming Group N.V. | 840.28M | -4.56% | 26,882 | 386.75M |
| 388 | CTY | City Therapeutics, Inc. | 823.97M | -13.25% | 360,563 | 14.34M |
| 389 | ANNX | Annexon, Inc. | 823.72M | 3.70% | 4,456,379 | - |
| 390 | PHR | Phreesia, Inc. | 817.47M | 7.69% | 524,297 | 507.79M |
| 391 | ARDX | Ardelyx, Inc. | 816.09M | 8.09% | 10,879,240 | 468.22M |
| 392 | INMD | InMode Ltd. | 815.94M | 0.82% | 802,149 | 374.63M |
| 393 | BBTX | Bambusa Therapeutics, Inc. | 810.49M | -0.56% | 252,358 | - |
| 394 | CGEM | Cullinan Therapeutics, Inc. | 804.43M | -20.63% | 1,962,782 | - |
| 395 | ABUS | Arbutus Biopharma Corporation | 804.25M | 4.77% | 2,780,768 | 181.72M |
| 396 | PACB | Pacific Biosciences of California, Inc. | 795.73M | 4.92% | 19,025,525 | 159.27M |
| 397 | DNA | Ginkgo Bioworks Holdings, Inc. | 785.19M | 8.36% | 2,402,051 | 132.42M |
| 398 | VREX | Varex Imaging Corporation | 780.58M | -0.05% | 647,246 | 865.00M |
| 399 | COLL | Collegium Pharmaceutical, Inc. | 770.10M | -0.32% | 804,568 | 808.21M |
| 400 | CTKB | Cytek Biosciences, Inc. | 763.65M | -1.43% | 1,572,029 | 206.71M |
| 401 | SANA | Sana Biotechnology, Inc. | 760.38M | 4.10% | 2,643,614 | - |
| 402 | OABI | OmniAb, Inc. | 755.56M | 0.58% | 1,144,316 | 40.21M |
| 403 | ACHV | Achieve Life Sciences, Inc. | 718.26M | 3.71% | 1,395,427 | - |
| 404 | WVE | Wave Life Sciences, Inc. | 712.98M | 0.98% | 2,747,684 | 70.92M |
| 405 | ATTO | Attovia Therapeutics, Inc. | 712.16M | 1.21% | 328,085 | 1.80M |
| 406 | SGMT | Sagimet Biosciences Inc. | 708.73M | 0.45% | 756,456 | - |
| 407 | STLN | Starling Oncology, Inc. | 706.28M | 9.31% | 1,690,204 | 587.24M |
| 408 | SLDB | Solid Biosciences Inc. | 696.96M | 3.50% | 1,058,605 | - |
| 409 | CADL | Candel Therapeutics, Inc. | 691.35M | 2.44% | 995,153 | - |
| 410 | GERN | Geron Corporation | 690.66M | 15.59% | 25,365,452 | 217.52M |
| 411 | AURA | Aura Biosciences, Inc. | 689.64M | 6.57% | 1,002,672 | - |
| 412 | FDMT | 4D Molecular Therapeutics, Inc. | 678.12M | 2.72% | 765,242 | 92.01M |
| 413 | OBX | Obsidian Therapeutics, Inc. | 677.65M | -17.08% | 545,362 | - |
| 414 | KURA | Kura Oncology, Inc. | 676.10M | -23.08% | 7,543,073 | 77.23M |
| 415 | AVBP | ArriVent BioPharma, Inc. | 665.65M | 3.69% | 1,860,458 | - |
| 416 | ZVRA | Zevra Therapeutics, Inc. | 665.26M | 8.97% | 2,067,472 | 147.76M |
| 417 | DSGN | Design Therapeutics, Inc. | 663.37M | 2.51% | 315,622 | - |
| 418 | LXRX | Lexicon Pharmaceuticals, Inc. | 662.98M | 2.05% | 1,949,171 | 41.47M |
| 419 | IMMX | Immix Biopharma, Inc. | 660.32M | 3.24% | 1,240,440 | - |
| 420 | OLMA | Olema Pharmaceuticals, Inc. | 659.73M | 2.59% | 1,092,430 | - |
| 421 | IAM | Iambic Therapeutics, Inc. | 641.81M | 0.37% | 293,037 | 18.25M |
| 422 | APMD | Apnimed, Inc. | 635.29M | 1.33% | 604,936 | 115.12M |
| 423 | HELP | Helus Pharma Inc. | 634.89M | -3.77% | 1,154,358 | - |
| 424 | SLBT | SL Science Holding Limited | 633.00M | -9.02% | 39,583 | 3.27M |
| 425 | IRWD | Ironwood Pharmaceuticals, Inc. | 625.43M | 8.14% | 2,569,546 | 389.32M |
| 426 | ANL | Adlai Nortye Group Ltd. | 620.15M | 0.52% | 238,845 | 18.06M |
| 427 | DBVT | DBV Technologies S.A. | 613.68M | -1.34% | 378,356 | 3.74M |
| 428 | TCMD | Tactile Systems Technology, Inc. | 610.89M | 10.05% | 861,884 | 356.42M |
| 429 | NVCT | Nuvectis Pharma, Inc. | 603.74M | -4.19% | 373,796 | - |
| 430 | AVR | Anteris Technologies Global Corp. | 596.66M | 9.29% | 1,157,692 | 2.24M |
| 431 | SOPH | SOPHiA GENETICS SA | 595.47M | 1.23% | 1,343,842 | 90.97M |
| 432 | CBIO | Crescent Biopharma, Inc. | 591.94M | 5.90% | 172,879 | 11.88M |
| 433 | BCAX | Bicara Therapeutics Inc. | 586.95M | -1.00% | 1,052,937 | - |
| 434 | DMAC | DiaMedica Therapeutics Inc. | 581.32M | 7.80% | 407,433 | - |
| 435 | EVO | Evotec SE | 576.18M | 0.65% | 55,733 | 819.47M |
| 436 | MYGN | Myriad Genetics, Inc. | 574.85M | -0.50% | 2,114,943 | 806.60M |
| 437 | NRC | NRC Health | 570.22M | 11.63% | 247,542 | 143.79M |
| 438 | ACRS | Aclaris Therapeutics, Inc. | 569.57M | -1.74% | 2,047,931 | 8.22M |
| 439 | PBYI | Puma Biotechnology, Inc. | 552.33M | 4.70% | 475,339 | 231.24M |
| 440 | NGNE | Neurogene Inc. | 551.91M | 3.30% | 209,063 | 925.00K |
| 441 | VALN | Valneva SE | 550.60M | 2.18% | 6,669 | 163.30M |
| 442 | SRZN | Surrozen, Inc. | 549.70M | 4.32% | 231,144 | 11.51M |
| 443 | ENTX | Entera Bio Ltd. | 544.38M | 2.62% | 291,752 | 42.00K |
| 444 | EVH | Evolent Health, Inc. | 542.68M | 11.63% | 2,247,504 | 2.10B |
| 445 | FLGT | Fulgent Genetics, Inc. | 541.50M | 1.60% | 364,050 | 323.93M |
| 446 | CLYM | Climb Bio, Inc. | 535.31M | -4.41% | 1,046,311 | - |
| 447 | OVID | Ovid Therapeutics Inc. | 535.12M | 14.17% | 3,615,963 | 1.58M |
| 448 | SGHT | Sight Sciences, Inc. | 533.25M | 2.76% | 630,094 | 83.38M |
| 449 | CAPR | Capricor Therapeutics, Inc. | 520.34M | 8.62% | 6,388,686 | 11.13M |
| 450 | STTK | Shattuck Labs, Inc. | 514.86M | -6.22% | 870,985 | 1.00M |
| 451 | ANGO | AngioDynamics, Inc. | 514.75M | 4.35% | 869,368 | 325.38M |
| 452 | DCTH | Delcath Systems, Inc. | 513.89M | 2.85% | 395,382 | 95.42M |
| 453 | CTMX | CytomX Therapeutics, Inc. | 512.06M | 7.80% | 6,602,340 | 18.30M |
| 454 | RGNX | REGENXBIO Inc. | 510.94M | 1.44% | 1,311,301 | 174.48M |
| 455 | FTH | Faeth Therapeutics, Inc. | 510.87M | 0.61% | 237,062 | - |
| 456 | RCEL | AVITA Medical, Inc. | 504.42M | 6.39% | 536,426 | 75.63M |
| 457 | MCTA | Charming Medical Limited | 504.26M | - | - | 4.81M |
| 458 | INDP | Indaptus Therapeutics, Inc. | 503.75M | 1.23% | 111,413 | - |
| 459 | YDES | YD Bio Limited | 495.82M | 9.46% | 81,376 | 1.24M |
| 460 | ETRA | Electra Therapeutics, Inc. | 495.23M | -2.23% | 437,407 | - |
| 461 | EOLS | Evolus, Inc. | 493.40M | 1.36% | 831,884 | 316.49M |
| 462 | ARVN | Arvinas, Inc. | 486.47M | 4.94% | 1,235,215 | 275.30M |
| 463 | CERS | Cerus Corporation | 485.68M | 2.99% | 2,515,242 | 226.57M |
| 464 | MNPR | Monopar Therapeutics Inc. | 482.61M | 2.88% | 189,688 | - |
| 465 | SENS | Senseonics Holdings, Inc. | 476.40M | 1.69% | 740,056 | 48.55M |
| 466 | AQST | Aquestive Therapeutics, Inc. | 476.36M | -2.32% | 3,315,831 | 48.84M |
| 467 | GYRE | Gyre Therapeutics, Inc. | 469.73M | -0.23% | 256,151 | 109.82M |
| 468 | MDXG | MiMedx Group, Inc. | 467.69M | -1.38% | 1,840,656 | 303.73M |
| 469 | SRTA | Strata Critical Medical, Inc. | 463.57M | 16.89% | 2,572,836 | 280.76M |
| 470 | NPCE | NeuroPace, Inc. | 459.60M | 8.77% | 226,049 | 106.99M |
| 471 | MASS | 908 Devices Inc. | 456.94M | 3.61% | 313,053 | 60.84M |
| 472 | TKNO | Alpha Teknova, Inc. | 454.75M | 0.41% | 372,185 | 43.70M |
| 473 | BWAY | BrainsWay Ltd. | 451.98M | 0.54% | 92,270 | 60.70M |
| 474 | PHAT | Phathom Pharmaceuticals, Inc. | 451.56M | -0.96% | 1,514,273 | 274.88M |
| 475 | OCS | Oculis Holding AG | 449.41M | -4.59% | 550,912 | 1.12M |
| 476 | EPRX | Eupraxia Pharmaceuticals Inc. | 446.81M | -1.67% | 661,207 | - |
| 477 | RLMD | Relmada Therapeutics, Inc. | 444.81M | -2.11% | 2,637,252 | - |
| 478 | CRMD | CorMedix Inc. | 441.16M | 1.80% | 1,494,327 | 462.25M |
| 479 | SSII | SS Innovations International, Inc. | 440.85M | -5.58% | 31,814 | 52.40M |
| 480 | CARL | Carlsmed, Inc. | 439.30M | 12.50% | 91,235 | 63.30M |
| 481 | SI | Shoulder Innovations, Inc. | 436.37M | 5.75% | 87,153 | 60.06M |
| 482 | TLRY | Tilray Brands, Inc. | 434.12M | 11.70% | 12,715,325 | 963.10M |
| 483 | PRTA | Prothena Corporation plc | 430.46M | 2.13% | 289,718 | 54.53M |
| 484 | PRLD | Prelude Therapeutics Incorporated | 420.22M | 7.94% | 377,986 | 22.42M |
| 485 | EDIT | Editas Medicine, Inc. | 420.04M | 5.19% | 2,370,441 | 47.01M |
| 486 | KMDA | Kamada Ltd. | 417.53M | 2.34% | 107,096 | 191.85M |
| 487 | RZLT | Rezolute, Inc. | 414.87M | -1.37% | 1,076,226 | - |
| 488 | ALT | Altimmune, Inc. | 409.46M | 3.19% | 3,480,179 | 31.00K |
| 489 | ALLO | Allogene Therapeutics, Inc. | 409.41M | 5.80% | 16,534,520 | 4.64M |
| 490 | ASMB | Assembly Biosciences, Inc. | 403.55M | -0.50% | 269,152 | 74.85M |
| 491 | OFIX | Orthofix Medical Inc. | 395.92M | 10.96% | 1,172,424 | 833.19M |
| 492 | TECX | Tectonic Therapeutic, Inc. | 391.96M | 5.64% | 221,760 | - |
| 493 | BLSM | BlossomHill Therapeutics, Inc. | 388.41M | -1.53% | 297,390 | - |
| 494 | ZURA | Zura Bio Limited | 387.71M | 0.88% | 1,948,341 | - |
| 495 | VMD | Viemed Healthcare, Inc. | 383.93M | 6.61% | 233,086 | 301.61M |
| 496 | CCCC | C4 Therapeutics, Inc. | 383.22M | -2.96% | 1,975,584 | 35.04M |
| 497 | AVTX | Avalo Therapeutics, Inc. | 379.16M | -2.48% | 1,379,257 | 59.00K |
| 498 | MOBI | Mobia Medical, Inc. | 374.52M | 12.84% | 380,553 | 45.28M |
| 499 | LYEL | Lyell Immunopharma, Inc. | 374.19M | 41.78% | 1,102,200 | 27.00K |
| 500 | MPLT | MapLight Therapeutics, Inc. | 372.64M | -1.54% | 389,927 | - |